AIP
FSTX

Ameritas Investment Partners’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Ameritas Investment Partners’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-271
Closed -$11K – 3139
2019
Q1 		$11K Hold
271
– – ﹤0.01% 2677
2018
Q4 		$11K Hold
271
– – ﹤0.01% 2643
2018
Q3 		$13K Hold
271
– – ﹤0.01% 2745
2018
Q2 		$13K Buy
+271
New +$15K ﹤0.01% 2753

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameritas Investment Partners's FSTX Position: Q2 2019 in Review

Ameritas Investment Partners sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q2 2019, closing a stake of 271 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in FSTX in Q2 2018 and held it in 4 quarters. The position peaked at $13K in Q3 2018. 50 funds tracked by Wall St. Rank hold FSTX as of Q2 2019.

  • Ameritas Investment Partners reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 271 F-star Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $11K.
  • Ameritas Investment Partners first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Ameritas Investment Partners's F-star Therapeutics, Inc. Common Stock position peaked at $13K in Q3 2018.
  • 50 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.